Uehleke, B; Schaper, S; Dienel, A; Schlaefke, S; Stange, R (2012). Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder. Phytomedicine, 19(8-9):665-671.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
0 downloads since deposited on 16 Nov 2012
0 downloads since 12 months
0 downloads since 12 months
Additional indexing
Item Type: | Journal Article, refereed, original work |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Institute of Complementary Medicine |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Life Sciences > Molecular Medicine
Life Sciences > Pharmacology Life Sciences > Pharmaceutical Science Life Sciences > Drug Discovery Health Sciences > Complementary and Alternative Medicine |
Language: | English |
Date: | 2012 |
Deposited On: | 16 Nov 2012 15:49 |
Last Modified: | 23 Jan 2022 22:45 |
Publisher: | Elsevier |
ISSN: | 0944-7113 |
OA Status: | Closed |
Free access at: | Publisher DOI. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1016/j.phymed.2012.02.020 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Permanent URL: https://doi.org/10.5167/uzh-66686
Download
Article Networks
Authors, Affiliations, Collaborations

Charité – Universitätsmedizin Berlin, Berlin, Germany
Hochschule für Gesundheit, Bochum, Germany
Abt. Komplementaermedizin, Zurich, Switzerland
Hochschule für Gesundheit, Bochum, Germany
Abt. Komplementaermedizin, Zurich, Switzerland
Charité – Universitätsmedizin Berlin, Berlin, Germany
Dr. Willmar Schwabe Pharmaceuticals, Karlsruhe, Germany
Dr. Willmar Schwabe Pharmaceuticals, Karlsruhe, Germany
Charité – Universitätsmedizin Berlin, Berlin, Germany